The peroxisome proliferator activated receptorγ2 (PPARγ2) Pro12Ala variant:: lack of association with type 2 diabetes in obese and non obese Tunisian patients

被引:20
作者
Bouassida, KZ
Chouchane, L
Jellouli, K
Chérif, S
Haddad, S
Gabbouj, S
Danguir, J [1 ]
机构
[1] Natl Inst Nutr, Serv Expt Nutr, Beijing 1007, Peoples R China
[2] Fac Med, Lab Mol Immune Oncol, Monastir, Tunisia
关键词
PPAR gamma 2; Pro12Ala polymorphism; obesity; type; 2; diabetes;
D O I
10.1016/S1262-3636(07)70177-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Peroxisome proliferator activated receptor gamma(2) (PPAR gamma(2)) is a nuclear receptor that regulates adipocyte differentiation, lipid metabolism and probably insulin sensitivity. There have been several reports on the relationship between the PPAR gamma(2) Pro12Ala genotype and the development of obesity or type 2 diabetes. We designed a case-controlled study to investigate the potential association of the genetic variation of the PPAR,12 gene with type 2 diabetes in Tunisians. Methods: We used the polymerase chain reaction and restriction enzyme digestion to characterize the variation of the Pro12Ala polymorphism of the PPAR,12 gene in 242 unrelated Tunisian patients with type 2 diabetes and 246 healthy control subjects. Results: Analysis of the Pro12Ala polymorphism of the PPAR gamma(2) gene in patients with type 2 diabetes and in control subjects revealed no significant differences in the PPAR gamma(2) allele frequencies between diabetic patients and control subjects. However the PPAR gamma(2) Ala 12 allele was found significantly associated with a high level of systolic blood pressure in diabetic patients. Stratification of diabetic patients on obese and non obese subjects showed non significant differences in the PPAR gamma(2) Ala 12 frequency between the two groups. Conclusion: These results suggest that the PPAR gamma(2) gene is unlikely a major gene for type 2 diabetes mellitus or obesity in Tunisian subjects.
引用
收藏
页码:119 / 123
页数:5
相关论文
共 29 条
[1]   The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes [J].
Altshuler, D ;
Hirschhorn, JN ;
Klannemark, M ;
Lindgren, CM ;
Vohl, MC ;
Nemesh, J ;
Lane, CR ;
Schaffner, SF ;
Bolk, S ;
Brewer, C ;
Tuomi, T ;
Gaudet, D ;
Hudson, TJ ;
Daly, M ;
Groop, L ;
Lander, ES .
NATURE GENETICS, 2000, 26 (01) :76-80
[2]   PPARγ, the ultimate thrifty gene [J].
Auwerx, J .
DIABETOLOGIA, 1999, 42 (09) :1033-1049
[3]   Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension [J].
Barroso, I ;
Gurnell, M ;
Crowley, VEF ;
Agostini, M ;
Schwabe, JW ;
Soos, MA ;
Maslen, GL ;
Williams, TDM ;
Lewis, H ;
Schafer, AJ ;
Chatterjee, VKK ;
O'Rahilly, S .
NATURE, 1999, 402 (6764) :880-883
[4]   Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations [J].
Beamer, BA ;
Yen, CJ ;
Andersen, BE ;
Muller, D ;
Elahi, D ;
Cheskin, LJ ;
Andres, R ;
Roth, J ;
Shuldiner, AR .
DIABETES, 1998, 47 (11) :1806-1808
[5]   Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: Binding and activation correlate with antidiabetic actions in db/db mice [J].
Berger, J ;
Bailey, P ;
Biswas, C ;
Cullinan, CA ;
Doebber, TW ;
Hayes, NS ;
Saperstein, R ;
Smith, RG ;
Leibowitz, MD .
ENDOCRINOLOGY, 1996, 137 (10) :4189-4195
[6]   The human peroxisome proliferator-activated receptor γ2 (PPARγ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes [J].
Caramori, ML ;
Canani, LH ;
Costa, LA ;
Gross, JL .
DIABETES, 2003, 52 (12) :3010-3013
[7]   A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity [J].
Deeb, SS ;
Fajas, L ;
Nemoto, M ;
Pihlajamäki, J ;
Mykkänen, L ;
Kuusisto, J ;
Laakso, M ;
Fujimoto, W ;
Auwerx, J .
NATURE GENETICS, 1998, 20 (03) :284-287
[8]   The peroxisome poliferator-activated receptor-γ2 Pro12Ala variant -: Association with type 2 diabetes and trait differences [J].
Douglas, JA ;
Erdos, MR ;
Watanabe, RM ;
Braun, A ;
Johnston, CL ;
Oeth, P ;
Mohlke, KL ;
Valle, TT ;
Ehnholm, C ;
Buchanan, TA ;
Bergman, RN ;
Collins, FS ;
Boehnke, M ;
Tuomilehto, J .
DIABETES, 2001, 50 (04) :886-890
[9]  
DYER P, 1994, HLA DIS, P93
[10]   Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-γ2 (PPAR-γ2):: divergent modulating effects on body mass index in obese and lean Caucasian men [J].
Ek, J ;
Urhammer, SA ;
Sorensen, TIA ;
Andersen, T ;
Auwerx, J ;
Pedersen, O .
DIABETOLOGIA, 1999, 42 (07) :892-895